×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
19617202 2011
×
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
21501481 2011
×
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
Mammary Neoplasms
0.500
Biomarker
CTD_human
[The correlation between chemotherapeutic efficacy and breast cancer susceptibility gene 1 and class IIIβ-tubulin protein expression in non-small cell lung cancer patients].
21781528 2011
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Therapeutic
CTD_human
Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
19617202 2011
×
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis.
20458558 2011
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Therapeutic
CTD_human
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
20197467 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Therapeutic
CTD_human
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
19896266 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
20197467 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
20332317 2010
×
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
Mammary Neoplasms
0.500
Biomarker
CTD_human
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.
20479250 2010
×
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Adjuvant systemic therapy for breast cancer in BRCA1BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
20135344 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
19896266 2010
×
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
Mammary Neoplasms
0.500
Biomarker
CTD_human
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.
19685490 2010
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Mammary Neoplasms
0.500
Biomarker
CTD_human
Subtle variations in Pten dose determine cancer susceptibility.
20400965 2010
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Mammary Neoplasms
0.500
Biomarker
CTD_human
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.
19685490 2010
×
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Adjuvant systemic therapy for breast cancer in BRCA1BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
20135344 2010
×
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
Mammary Neoplasms
0.500
Biomarker
CTD_human
ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.
20966540 2010
×
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
Mammary Neoplasms
0.500
Biomarker
CTD_human
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response.
20948315 2010
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Mammary Neoplasms
0.500
Biomarker
CTD_human
Synchronous bilateral breast carcinoma in a patient with cowden syndrome: a case report with morphologic, immunohistochemical and genetic analysis.
19968660 2010
×
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.
20104649 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Therapeutic
CTD_human
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
20332317 2010
×
Entrez Id: 11200
Gene Symbol: CHEK2
CHEK2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
18297428 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
mRNA levels of 10 BCAR genes (AKT1, AKT2, BCAR1, BCAR3, EGFR, ERBB2 , GRB7, SRC, TLE3, and TRERF1) were measured in estrogen receptor-positive breast tumors using quantitative reverse-transcriptase polymerase chain reaction.
19075277 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
19801490 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
19436038 2009